(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.
Sol Gel Technologies's earnings in 2025 is -$10,580,000.On average, 1 Wall Street analyst forecast SLGL's earnings for 2025 to be -$11,143,048, with the lowest SLGL earnings forecast at -$11,143,048, and the highest SLGL earnings forecast at -$11,143,048.
In 2026, SLGL is forecast to generate -$7,800,134 in earnings, with the lowest earnings forecast at -$7,800,134 and the highest earnings forecast at -$7,800,134.